Session 5: Lessons from Primary Prostate Cancer
29th Annual PCF Scientific Retreat: October 28, 2022 | 1:20 PM – 2:40 PM
Moderator: Jiaoti Huang, PhD
Duke University
Molecular Signatures to Risk-Stratify Intermediate-Risk Primary Prostate Cancer
Jiaoti Huang, PhD
Duke University
Cellular Origins of Therapy Resistance / Biologic Features in Primary Prostate Cancer that may Inform Outcome or Therapy Response
Mary-Ellen Taplin, MD
Dana-Farber Cancer Institute
Predicting Prostate Cancer Outcome and Molecular Subtype with Artificial Intelligence
Tamara Lotan, MD
Johns Hopkins University
Lineage Plasticity in Cancers of the Lung and Prostate
Charles Rudin, MD, PhD
Memorial Sloan Kettering Cancer Center